Related Experiment Video
Updated: Jul 5, 2026
06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Advances in type I diabetes associated tolerance mechanisms
A A Chentoufi1, N R Binder, N Berka
1Cellular and Molecular Immunology Laboratory, Department of Ophthalmology, University of California Irvine-Medical Center, 101 City Drive, Bldg 55, 2nd floor, Orange, CA 92868, USA. aalamich@uci.edu
Scandinavian Journal of Immunology
|May 17, 2008
Summary
Type 1 diabetes involves T-cell destruction of insulin cells. Medullary thymic epithelial cells and regulatory T cells are key to immune tolerance, influencing disease risk.
Area of Science:
- Immunology
- Endocrinology
- Genetics
Background:
- Type 1 diabetes (T1D) is an autoimmune condition where T cells destroy pancreatic beta cells.
- Genetic factors influencing T1D risk impact immune tolerance mechanisms.
- Medullary thymic epithelial cells (mTEC) and regulatory T cells (Treg) are crucial for maintaining self-tolerance.
Purpose of the Study:
- To review central and peripheral T-cell tolerance mechanisms in Type 1 diabetes.
- To highlight the role of mTEC and Treg cells in T1D pathogenesis.
- To discuss emerging concepts in T1D immunology.
Main Methods:
- Literature review of recent research on T-cell tolerance and T1D.
- Analysis of genetic associations with T1D susceptibility.
- Examination of the function of mTEC and Treg cells in autoimmunity.
Main Results:
- mTEC express self-antigens essential for T-cell selection and Treg differentiation.
- Peripheral Treg cells are critical for dominant peripheral T-cell tolerance.
- T1D susceptibility genes modulate autoreactive T-lymphocyte generation and activation.
Conclusions:
- Central and peripheral T-cell tolerance, involving mTEC and Treg cells, are critical in Type 1 diabetes.
- Dysregulation of these tolerance mechanisms contributes to T1D development.
- Understanding these processes offers insights into T1D prevention and treatment.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...